Papers associated with

Limit to papers also referencing gene:

???pagination.result.count???

???pagination.result.page??? 1 2 3 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

	Early development of descending pathways from the brain stem to the spinal cord in Xenopus laevis., van Mier P., Anat Embryol (Berl). January 1, 1984; 170 (3): 295-306.
	Decreased TRH receptor mRNA activity precedes homologous downregulation: assay in oocytes., Oron Y., Science. December 4, 1987; 238 (4832): 1406-8.
	Horseradish peroxidase study of tectal afferents in Xenopus laevis with special emphasis on their relationship to the lateral-line system., Zittlau KE., Brain Behav Evol. January 1, 1988; 32 (4): 208-19.
	Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology., Verdoorn TA., Mol Pharmacol. September 1, 1988; 34 (3): 298-307.
	Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist., Ferkany JW., J Pharmacol Exp Ther. July 1, 1989; 250 (1): 100-9.
	RNA template-specific polymerase chain reaction (RS-PCR): a novel strategy to reduce dramatically false positives., Shuldiner AR., Gene. July 2, 1990; 91 (1): 139-42.
	Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes., Dawson TL., Mol Pharmacol. December 1, 1990; 38 (6): 779-84.
	Two nonallelic insulin genes in Xenopus laevis are expressed differentially during neurulation in prepancreatic embryos., Shuldiner AR., Proc Natl Acad Sci U S A. September 1, 1991; 88 (17): 7679-83.
	Thyrotropin-releasing hormone (TRH) and phorbol myristate acetate decrease TRH receptor messenger RNA in rat pituitary GH3 cells: evidence that protein kinase-C mediates the TRH effect., Fujimoto J., Mol Endocrinol. October 1, 1991; 5 (10): 1527-32.
	Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials., Randle JC., Mol Pharmacol. February 1, 1992; 41 (2): 337-45.
	Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors., Curras MC., Mol Pharmacol. March 1, 1992; 41 (3): 520-6.
	Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution., Randle JC., Eur J Pharmacol. May 14, 1992; 215 (2-3): 237-44.
	G alpha 11 and G alpha q guanine nucleotide regulatory proteins differentially modulate the response to thyrotropin-releasing hormone in Xenopus oocytes., Lipinsky D., FEBS Lett. July 28, 1992; 307 (2): 237-40.
	Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes., Sakuta H., Br J Pharmacol. July 1, 1993; 109 (3): 866-72.
	Molecular cloning of a functional human thyrotropin-releasing hormone receptor., Matre V., Biochem Biophys Res Commun. August 31, 1993; 195 (1): 179-85.
	Differential effects of cytoskeletal agents on hemispheric functional expression of cell membrane receptors in Xenopus oocytes., Matus-Leibovitch N., Cell Mol Neurobiol. December 1, 1993; 13 (6): 625-37.
	Pagliaccio, a member of the Eph family of receptor tyrosine kinase genes, has localized expression in a subset of neural crest and neural tissues in Xenopus laevis embryos., Winning RS., Mech Dev. June 1, 1994; 46 (3): 219-29.
	Independent external calcium entry and cellular calcium mobilization in Xenopus oocytes., Lupu-Meiri M., Cell Calcium. July 1, 1994; 16 (1): 20-8.
	The hemispheric functional expression of the thyrotropin-releasing-hormone receptor is not determined by the receptors' physical distribution., Matus-Leibovitch N., Biochem J. October 1, 1994; 303 ( Pt 1) 129-34.
	Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations., Ebert B., Mol Pharmacol. November 1, 1994; 46 (5): 957-63.
	The two nonallelic insulin-like growth factor-I genes in Xenopus laevis are differentially regulated during development., Perfetti R., Endocrinology. November 1, 1994; 135 (5): 2037-44.
	Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1., Stoiber H., AIDS. January 1, 1995; 9 (1): 19-26.
	Truncation of the thyrotropin-releasing hormone receptor carboxyl tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells., Matus-Leibovitch N., J Biol Chem. January 20, 1995; 270 (3): 1041-7.
	L-2-amino-3-phosphonopropionic acid competitively antagonizes metabotropic glutamate receptors 1 alpha and 5 in Xenopus oocytes., Saugstad JA., Eur J Pharmacol. April 28, 1995; 289 (2): 395-7.
	Platelet-derived growth factor receptor is a novel modulator of type A gamma-aminobutyric acid-gated ion channels., Valenzuela CF., Mol Pharmacol. December 1, 1995; 48 (6): 1099-107.
	Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function., Valenzuela CF., J Biol Chem. July 5, 1996; 271 (27): 16151-9.
	Different characteristics of AMPA receptor agonists acting at AMPA receptors expressed in Xenopus oocytes., Wahl P., Eur J Pharmacol. July 18, 1996; 308 (2): 211-8.
	RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors., Van Hooft JA., Eur J Pharmacol. March 19, 1997; 322 (2-3): 229-33.
	cDNA cloning of nuclear localization signal binding protein NBP60, a rat homologue of lamin B receptor, and identification of binding sites of human lamin B receptor for nuclear localization signals and chromatin., Kawahire S., J Biochem. May 1, 1997; 121 (5): 881-9.
	Pharmacology and toxicology of ATOA, an AMPA receptor antagonist and a partial agonist at GluR5 receptors., Wahl P., Neuropharmacology. January 1, 1998; 37 (10-11): 1205-10.
	Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family., Spicer AP., J Biol Chem. January 23, 1998; 273 (4): 1923-32.
	Effect of bay K 8644 (-) and the beta2a subunit on Ca2+-dependent inactivation in alpha1C Ca2+ channels., Noceti F., J Gen Physiol. March 1, 1998; 111 (3): 463-75.
	Maitotoxin (MTX) activates a nonselective cation channel in Xenopus laevis oocytes., Bielfeld-Ackermann A., Pflugers Arch. August 1, 1998; 436 (3): 329-37.
	Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8., Corti C., Eur J Neurosci. December 1, 1998; 10 (12): 3629-41.
	Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid., Møller EH., Chirality. January 1, 1999; 11 (10): 752-9.
	Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C., Grimberg H., Br J Pharmacol. March 1, 1999; 126 (5): 1097-106.
	Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem., Kindler CH., Anesthesiology. April 1, 1999; 90 (4): 1092-102.
	Hepatitis C virus core protein interacts with a human DEAD box protein DDX3., Owsianka AM., Virology. May 10, 1999; 257 (2): 330-40.
	Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA., Stensbøl TB., Eur J Pharmacol. September 10, 1999; 380 (2-3): 153-62.
	6-Chloro-3'-nitroflavone is a potent ligand for the benzodiazepine binding site of the GABA(A) receptor devoid of intrinsic activity., Viola H., Pharmacol Biochem Behav. February 1, 2000; 65 (2): 313-20.
	Rapid desensitization of the TRH receptor and persistent desensitization of its constitutively active mutant., Zaltsman I., Br J Pharmacol. May 1, 2000; 130 (2): 315-20.
	Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors., Donevan SD., Mol Pharmacol. September 1, 2000; 58 (3): 614-23.
	Juxtamembrane regions in the third intracellular loop of the thyrotropin-releasing hormone receptor type 1 are important for coupling to Gq., Buck F., Endocrinology. October 1, 2000; 141 (10): 3717-22.
	Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist., Vogensen SB., Chirality. November 1, 2000; 12 (10): 705-13.
	Desensitization and internalization of human and xenopus gonadotropin-releasing hormone receptors expressed in alphaT4 pituitary cells using recombinant adenovirus., Hislop JN., Endocrinology. December 1, 2000; 141 (12): 4564-75.
	A functional water channel protein in the pathogenic bacterium Brucella abortus., Rodrı Guez MAC., Microbiology (Reading). December 1, 2000; 146 Pt 12 3251-3257.
	Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist., Stensbøl TB., Eur J Pharmacol. January 12, 2001; 411 (3): 245-53.
	Modulation of GABA(A) receptors by benzodiazepines and barbiturates is autonomous of PKC activation., Ghansah E., Neuropharmacology. March 1, 2001; 40 (3): 327-33.
	The small muscle-specific protein Csl modifies cell shape and promotes myocyte fusion in an insulin-like growth factor 1-dependent manner., Palmer S., J Cell Biol. May 28, 2001; 153 (5): 985-98.
	Differential internalization of mammalian and non-mammalian gonadotropin-releasing hormone receptors. Uncoupling of dynamin-dependent internalization from mitogen-activated protein kinase signaling., Hislop JN., J Biol Chem. October 26, 2001; 276 (43): 39685-94.

???pagination.result.page??? 1 2 3 ???pagination.result.next???